Intuitive Surgical Company Profile

22:45 EDT 18th June 2018 | BioPortfolio

Intuitive Surgical, Inc. (Nasdaq: ISRG) is the global technology leader in robotic-assisted minimally invasive surgery (MIS). The Company's da Vinci® Surgical System offers surgeons superior visualization, enhanced dexterity, greater precision and ergonomic comfort for the optimal performance of MIS. The da Vinci System enables surgeons to perform even complex procedures such as open-heart surgery through 1-2 cm incisions. This breakthrough is allowing hospitals everywhere to extend the benefits of MIS to a broader base of patients. An investment in an MIS initiative that is built on the da Vinci Surgical System platform can provide hospitals with greater return in the areas of market share growth, utilization mix, productivity and operational efficiencies. Improved operational efficiencies may include reduced incidence of complications and post-operative infections; reduced need for blood transfusions and post-operative pain management, simplified post-operative nursing care and reduced length of stay. The original prototype for Intuitive Surgical’s da Vinci System was developed in the late 1980s at the former Stanford Research Institute under contract to the U.S. Army. While initial work was funded in the interest of developing a system for performing battlefield surgery remotely, possible commercial applications were even more compelling: It was clear to those involved that this technology could accelerate the application of a minimally invasive surgical approach to a broader range of procedures. In 1995, Intuitive Surgical was founded to test this theory. In January 1999, Intuitive launched the da Vinci Surgical System, and in 2000, it became the first robotic surgical system cleared by the FDA for general laparoscopic surgery. In the following years, the FDA cleared the da Vinci Surgical System for thoracoscopic (chest) surgery, for cardiac procedures performed with adjunctive incisions, urologic and gynecologic procedures. In June 2000, Intuitive Surgical conducted a successful initial public offering. In 2003, the Company acquired its principal competitor Computer Motion, strengthening its intellectual property holdings and ensuring its position as the world’s sole provider of robotic-assisted surgical systems. Today, over 500 da Vinci Systems are installed in hospitals worldwide. Intuitive Surgical currently has rights to over 300 U.S. and foreign patents, as well as patents pending. In addition to developing its own proprietary technologies, Intuitive Surgical has established relationships with several industry leaders including IBM Corporation, Massachusetts Institute of Technology (MIT) and Heartport, Inc. (Johnson & Johnson). The Company has also entered into industry collaborations with companies including Ethicon Endo-Surgery (Johnson & Johnson), Medtronic and Olympus Optical. Headquartered in Sunnyvale, California, Intuitive Surgical has more than 500 employees in offices worldwide. Intuitive Surgical’s sales for the 2005 fiscal year totaled $227.3 million, up 64% from $138.3 million in 2004. Recurring revenue totaled $102.7 million or 71% of total revenue in 2005, compared to $60 million in 2004. The da Vinci Prostatectomy procedure is currently the fastest-growing treatment for prostate cancer, which is the second leading cause of cancer-related death in men.


1266 Kifer Road, Building 101
United States of America


Phone: 408-523-2100
Fax: 408-523-1390

News Articles [395 Associated News Articles listed on BioPortfolio]

Intuitive Surgical invests $15M in Broncus Medical

A round of Series A financing involving Intuitive Surgical has brought in $15 million for San Jose, Calif.-based Broncus Medi -More- 

FDA clears expanded use of Intuitive Surgical's da Vinci SP device

The FDA has granted Intuitive Surgical 510(k) clearance for its da Vinci SP robot-assisted surgery device for use in procedur -More- 

Broncus Medical gets $15mm Series A investment from Intuitive Surgical

Broncus Medical Inc. (diagnostic and therapeutic technology for lung disease) raised $15mm in a Series A financing from surgical device maker Intuitive Surgical.

Broncus Medical raises $15m in Series A funding from Intuitive Surgical

Broncus Medical, a developer of diagnostic and therapeutic technology for lung disease, has raised $15m in Series A financing from Intuitive Surgical.

Robotic Surgery Pioneer Cuts It Close

Intuitive Surgical (ISRG) started with a very simple plan. That is, to make surgery less invasive with surgical robots.

Intuitive Surgical At The Cutting Edge

Intuitive Surgical's (ISRG) CEO Gary Guthart on Q1 2018 Results - Earnings Call Transcript

Intuitive Surgical's (ISRG) CEO Gary Guthart on Q4 2017 Results - Earnings Call Transcript

Drugs and Medications [58 Associated Drugs and Medications listed on BioPortfolio]

Ecolab [Ecolab Inc.]

Drug Facts

Ecolab [Ecolab Inc.]

Drug Facts

Endure 450 [Ecolab Inc.]

Drug Facts

Betadine [Purdue Products LP]

Betadine Surgical Scrub Povidone-iodine, 7.5%


TRISEPTIN Hand and Body Antiseptic – alcohol lotion CareFusion

PubMed Articles [1722 Associated PubMed Articles listed on BioPortfolio]

Psychometric properties of the intuitive eating scale-2 (IES-2) in a culturally diverse Hispanic American sample.

Intuitive eating is an adaptive eating tendency consistently associated with positive physical and mental health outcomes, including lower risk for obesity and eating disorders (EDs). Obesity rates ar...

Measuring surgical safety during minimally invasive surgical procedures: a validation study.

During the implementation of new interventions (i.e., surgical devices and technologies) in the operating room, surgical safety might be compromised. Current safety measures are insufficient in detect...

Robotic surgery: new robots and finally some real competition!

For the last 20 years, the predominant robot used in laparoscopic surgery has been Da Vinci by Intuitive Surgical. This monopoly situation has led to rising costs and relatively slow innovation. This...

DigBody: A new 3D modeling tool for nasal virtual surgery.

Recent studies have demonstrated that a significant number of surgical procedures for nasal airway obstruction (NAO) have a high rate of surgical failure. In part, this problem is due to the lack of r...

Revision PCL Reconstruction Review/Update.

The primary goal of this review is to update recent literature on revision PCL reconstruction and to discuss factors relevant to surgical failure, surgical indications and goals, patient evaluation, s...

Clinical Trials [2503 Associated Clinical Trials listed on BioPortfolio]

Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract

To assess the use of the da Vinci® Robotic Surgical System (Intuitive Surgical, Inc., Sunnyvale, CA) in transoral surgeries in patients with benign and malignant lesions of the oral cavit...

Robotic Assisted Versus Laparoscopic Cholecystectomy - Outcome and Cost Analyses of a Case-Matched Control Study

Case matched study on 50 consecutive patients undergoing robotic assisted cholecystectomy (Da Vinci Robot, Intuitive Surgical). These patients are matched 1:1 to 50 patients with conventio...

A Pilot Study Assessing Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck

This study is designed to investigate if transoral surgery with the patient in the seated position utilizing the da Vinci® Robotic Surgical System (Intuitive Surgical, Inc., Sunnyvale...

Public Health Messages to Address Vaccine Hesitancy

Views on vaccines range from those who are strongly supportive to those who are stridently opposed and will not budge from identity-based core beliefs about vaccines. In between these pole...

To Evaluate the Robotic Surgery in a Dedicated Multidisciplinary Pediatric Program and the Relative Cost of Robotic Surgery

Robotic minimally invasive surgery has been rapidly adopted for a wide variety of surgical procedures in adult patients across a broad spectrum of surgical specialties. This has occurred d...

Companies [792 Associated Companies listed on BioPortfolio]

Intuitive Surgical

Intuitive Surgical, Inc. (Nasdaq: ISRG) is the global technology leader in robotic-assisted minimally invasive surgery (MIS). The Company's da Vinci® Surgical System offers surgeons superior visualiz...

First Surgical Partners Inc.

First Surgical Partners Inc. (“First Surgical”) operates two ambulatory surgery centers and a general acute care hospital in the Houston area. The surgeons that utilize ...

RF Surgical Systems Inc.

RF Surgical Systems, Inc. is the market leader in the detection and prevention of retained surgical items. The RF Surgical Detection System is the preferred solution in more than ...

For RF Surgical RF Surgical

RF Surgical Systems, Inc. is the market leader in the prevention and detection of retained surgical sponges. The RF Surgical Detection System is the preferred solution in more tha...

RF Surgical, Inc.

RF Surgical Systems, Inc. is the market leader in the detection and prevention of retained surgical sponges. The RF Surgical Detection System is the preferred solution in more tha...

More Information about "Intuitive Surgical" on BioPortfolio

We have published hundreds of Intuitive Surgical news stories on BioPortfolio along with dozens of Intuitive Surgical Clinical Trials and PubMed Articles about Intuitive Surgical for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Intuitive Surgical Companies in our database. You can also find out about relevant Intuitive Surgical Drugs and Medications on this site too.

Quick Search


Relevant Topic

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Corporate Database Quicklinks

Searches Linking to this Company Record